An Inconvenient Truth: Ciprofloxacin-Resistant Campylobacter

When Al Gore became a best-selling author with “An Inconvenient Truth” he warned about climate change.  When it comes to antibiotic resistance and the current situation of “Bad Bugs, No Drugs”, there are many voices warning us about a return Continue reading An Inconvenient Truth: Ciprofloxacin-Resistant Campylobacter

CRE Surveillance Data from France

Despite all the concern about the emergence of CRE pathogens worldwide, it is quite difficult to obtain hard quantitative, prospectively collected incidence figures. A recent article by Robert [1] and colleagues provides useful data from France.  Using a practical definition of carbapenem-non-susceptibility Continue reading CRE Surveillance Data from France

The Breakpoint Dilemma

As antibiotic resistance increases over the years, originally established susceptibility breakpoints (S-I-R) are becoming less relevant.   This ‘creep’ towards higher MICs over time is a unique but well-known feature of antimicrobials ultimately making these drugs obsolete. In the past, Continue reading The Breakpoint Dilemma